Department of Health
Dramatic proposals will force drug companies to cut prices of generic medicines back to September 1998 levels and abolish the category-D scheme which reimburses pharmacists for dispensing more expensive brand-name products when generic alternatives are not available.
British Journal of Healthcare Management, vol. 6, 2000, p. 162-163
Overview of recent developments to combat fraud and corruption in the NHS nationally under the Directorate of Counter-Fraud Services.
Committee of Public Accounts
London: TSO, 2000 (House of Commons papers. Session 1999/2000; HC 131)
The NHS Executive now expects the PFI deal for the new Dartford and Gravesham Hospital to result in savings of £5 million compared with an equivalent project under conventionally funded procurement instead of the £17 million originally estimated. Report concludes that the NHS failed to estimate the costs correctly; that the Trust failed to detect significant errors in the public sector comparator; that the Trust did not understand the full range of risks and potential rewards available to the private sector; and that the NHS must use its experience of the PFI to drive down advisers' costs.